Empower your life sciences business to close more deals with airSlate SignNow
airSlate SignNow regularly wins awards for ease of use and setup
See airSlate SignNow eSignatures in action
Our user reviews speak for themselves
Why choose airSlate SignNow
-
Free 7-day trial. Choose the plan you need and try it risk-free.
-
Honest pricing for full-featured plans. airSlate SignNow offers subscription plans with no overages or hidden fees at renewal.
-
Enterprise-grade security. airSlate SignNow helps you comply with global security standards.
Close more deals for Life Sciences
Close more deals for Life Sciences
Experience the benefits of airSlate SignNow today and revolutionize the way you handle document signing in the Life Sciences field. Start your free trial now and close more deals efficiently and securely.
Sign up for airSlate SignNow and close deals faster!
airSlate SignNow features that users love
Get legally-binding signatures now!
FAQs online signature
-
Where can I find the latest M&A deals?
Refinitiv (formerly Thomson Financial) is the premier source for information on individual M&A deals. Their data can be accessed through Refinitiv Workspace and Wharton Research Data Services. The database has details on all announced deals, whether completed or uncompleted.
-
What is the life sciences market outlook for 2024?
Life sciences in 2024 is expected to see cautious growth driven by strategic acquisitions and collaborations. While economic headwinds exist, particularly in China, overall M&A activity is predicted to rise, with pharma companies focusing on assets with high commercial potential.
-
What are the most recent M&A deals for healthcare?
Recent healthcare M&A deals: recent notable deals include Novo Holdings' acquisition of Catalent, CVS Health's acquisition of Oak Street Health, and Optum's acquisition of Amedisys.
-
What is the M&A activity in healthcare 2024?
Healthcare M&A activity remained robust in the first quarter of 2024, with 29 transactions vs. 28 in 2023. Biopharma was the most active healthcare subsector, representing 45% of deal volume, while Services activity remained dampened despite notable transactions such as Novo Holdings' acquisition of Catalent.
-
What is the EY M&A forecast?
Based on the Macroeconomics team's US economic outlook, the EY Deal Barometer estimates corporate M&A deal volume (for deals over $100 million) will gradually pick up, rising 20% in 2024, following a 17% contraction in 2023. (See Figure 1 below.)
-
What is the outlook for PWC life sciences?
We expect deal activity to remain strong in the second half of 2024 despite sustained headwinds. Some of the key considerations impacting the sector include: Continued regulatory uncertainty, particularly leading up to the US elections in November, as politicians around the world remain focused on drug pricing.
-
What is an example of a merger in healthcare?
The April 2023 announcement that California-based Kaiser Permanente was acquiring Pennsylvania-based Geisinger Health falls into the category of value-based care mergers.
-
What is the trend in healthcare mergers?
Hospital and health system mergers and acquisitions significantly increased in Q1 2024. ing to a report by Cain Brothers, a total of 18 hospital and health system transactions were announced in Q1, up from just 12 transactions in the first quarter of 2023.
Trusted e-signature solution — what our customers are saying
How to create outlook signature
do you want to make better sales Discovery calls then act like a doctor now a doctor doesn't judge their patients instead they accept the facts as they are so that they can then provide the most evidence-driven solution that they can so refrain from pitching your product on a discovery call until you've been through all of your questions understand the facts of the buyer situation before you start trying to like twist and and turn and manipulate the value that your product offers to them before he's trying to shove it down their throats and finally remember that you're the doctor you've seen and you've solved these problems hundreds of times over and over and over again on the other hand the buyer probably doesn't know how to fix this issue otherwise they'd have done it on their own that means like a doctor you should stay in control of the discovery process and then genuinely see if you can help
Show more